Bal Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 91.37 | 88.88 | 83.70 |
| Operating Expense | 80.98 | 80.48 | 73.29 |
| Net Profit | 1.53 | 1.16 | 3.70 |
| Net Profit Margin | 1.67% | 1.31% | 4.42% |
| Earning Per Share | 0.96 | 0.73 | 2.60 |
| EBIDTA | 10.39 | 8.41 | 10.79 |
| Effective Tax Rate | 4.81% | 0% | 0% |
Particulars
Sep 2026
Revenue91.37
Operating Expense80.98
Net Profit1.53
Net Profit Margin1.67
Earning Per Share0.96
EBIDTA10.39
Effective Tax Rate4.81
